arrow
R

Roger Ho

National University of Singapore
H指数:96
被引数:6.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chronopharmacology and implications for the safety and efficacy of anticonvulsants, antipsychotics, and antidepressants: A systematic review

时辰药理学及其对抗惊厥药、抗精神病药和抗抑郁药安全性及疗效的影响:一项系统综述

2026-09-250
PRE
The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analyses

胰高血糖素样肽1(GLP-1)受体激动剂对认知功能的影响:系统评价的系统评价和Meta分析的综述

2026-01-300
OAAI
Enriching Global Perspectives Through a Regional Lens: Recognition, Assessment, and Management of Tardive Dyskinesia in Southeast Asia

通过区域视角丰富全球观点:东南亚迟发性运动障碍的认知、评估和管理

2026-01-010
OAAI
The Clinical Utility of the Objective Measures for Diagnosing and Monitoring Attention-Deficit and Hyperactivity Disorder (ADHD) in Adults: A Systematic Review

客观测量在成人注意缺陷多动障碍(ADHD)诊断和监测中的临床实用性:一项系统综述

2025-12-190
OAAI
Effects of glutamatergic modulators on striatal activation, functional connectivity and reward in persons with major depressive disorder and healthy controls: A systematic review of fMRI studies

谷氨酸能调节剂对纹状体激活、功能连接和奖赏在重度抑郁症患者和健康对照者中的影响:一项fMRI研究的系统综述

2025-10-150
OAAI
Nonuniversality of inflammaging across human populations

人类群体中炎症衰老的非普适性

2025-06-300
PRE
Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implications

谷氨酸能调节剂是否应被视为具有创伤史的重度抑郁症成年患者的首选治疗方案?概念与临床意义

2025-05-260
OAAI